The FDA has delayed granting full approval of Novavax's COVID-19 vaccine despite it being on track to be cleared until ...

Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...

Continuing to ask questions on an issue that has been answered multiple times, by multiple people, introduces doubt and anxiety. Our children deserve better.

Medical researchers helped tame a worldwide pandemic, but they may be powerless against the financial disease rapidly ...

Against the backdrop of a rapidly expanding measles outbreak, what we need right now is urgent assistance from the federal government to support immunization and strengthen vaccine delivery, not more ...

Over the last two months, the pharmaceutical industry has remained on the sidelines as Health and Human Services Secretary Robert F. Kennedy Jr. and Elon Musk’s Department of Government Efficiency ...

Dr. Marks was asked to leave and then subsequently wrote that he did not want to become “subservient to [Secretary Kennedy’s] misinformation and lies.” Peter Marks is not a hero of the resistance but ...

It comes on the heels of the FDA's top vaccine scientist Peter Marks' exit from the agency, which will be effective April 5.

Clifford Lane, a 45-year veteran of the NIH and close confidant of Fauci as NIAID deputy director for clinical research, and NIAID microbiology and infectious diseases director Emily Erbelding, have ...

As the FDA’s top biologics official, Peter Marks oversaw regulation of cell and gene therapies. The departure of Marks and mass layoffs throughout the FDA raise concerns about the agency’s ability to ...

In this week’s edition of InnovationRx, we look at Trump's massive health agency layoffs, Palantir’s trade secret lawsuit, ...